PROLYMPHOCYTIC LEUKEMIA
Clinical trials for PROLYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new PROLYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for PROLYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough leukemias: targeted pill shows promise in Late-Stage trial
Disease control OngoingThis study tested a daily pill called ibrutinib in 154 people with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or B-cell prolymphocytic leukemia (B-PLL) that had come back or stopped responding to prior treatments. The goal was to see if the drug could c…
Matched conditions: PROLYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Kami Maddocks, MD • Aim: Disease control
Last updated May 17, 2026 02:01 UTC
-
New CMV strategy aims to protect stem cell transplant patients from dangerous infection
Disease control OngoingThis study looks at a modified approach to prevent and treat cytomegalovirus (CMV) infection in people who have had a donor stem cell transplant for blood cancers or disorders. About 153 participants are involved, and the goal is to see if changing when and how anti-CMV drugs are…
Matched conditions: PROLYMPHOCYTIC LEUKEMIA
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New pill shows promise for controlling blood cancer
Disease control OngoingThis study tests a new drug called acalabrutinib for people with chronic lymphocytic leukemia (CLL) or related blood cancers. The goal is to see if the drug is safe and can shrink or control the cancer. Participants take the drug by mouth, and the study tracks side effects and ho…
Matched conditions: PROLYMPHOCYTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Acerta Pharma BV • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
New combo therapy tested for returning leukemia
Disease control OngoingThis study tests whether adding rituximab to ibrutinib works better than ibrutinib alone for patients with chronic lymphocytic leukemia (CLL) that has come back after treatment. About 66 adults with relapsed CLL or related blood cancers will receive either ibrutinib alone or ibru…
Matched conditions: PROLYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 04, 2026 16:22 UTC